Answer
Lanreotide acetate may reduce intestinal absorption and relative bioavailability of co-administered ciclosporin through its gastrointestinal effects, potentially requiring ciclosporin dose adjustment to maintain therapeutic levels.
Sources for this answer
- Lanreotide ADVANZ PHARMA 120 mg solution for injection in a prefilled syringeADVANZ Pharma · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked